nodes	percent_of_prediction	percent_of_DWPC	metapath
Fenoldopam—Haemorrhage—Everolimus—kidney cancer	0.0045	0.00458	CcSEcCtD
Fenoldopam—Chest pain—Temsirolimus—kidney cancer	0.00448	0.00456	CcSEcCtD
Fenoldopam—Anxiety—Temsirolimus—kidney cancer	0.00446	0.00454	CcSEcCtD
Fenoldopam—Cardiac failure—Gemcitabine—kidney cancer	0.00446	0.00454	CcSEcCtD
Fenoldopam—Transaminases increased—Doxorubicin—kidney cancer	0.00437	0.00445	CcSEcCtD
Fenoldopam—Haemoglobin—Erlotinib—kidney cancer	0.00436	0.00444	CcSEcCtD
Fenoldopam—Haemorrhage—Erlotinib—kidney cancer	0.00434	0.00442	CcSEcCtD
Fenoldopam—Acute coronary syndrome—Sorafenib—kidney cancer	0.00429	0.00436	CcSEcCtD
Fenoldopam—Myocardial infarction—Sorafenib—kidney cancer	0.00426	0.00434	CcSEcCtD
Fenoldopam—Chest pain—Pazopanib—kidney cancer	0.00422	0.0043	CcSEcCtD
Fenoldopam—Flushing—Everolimus—kidney cancer	0.00417	0.00425	CcSEcCtD
Fenoldopam—Acute coronary syndrome—Sunitinib—kidney cancer	0.00412	0.0042	CcSEcCtD
Fenoldopam—Injection site reaction—Capecitabine—kidney cancer	0.0041	0.00417	CcSEcCtD
Fenoldopam—Blood creatinine increased—Gemcitabine—kidney cancer	0.00408	0.00415	CcSEcCtD
Fenoldopam—Urinary tract infection—Sunitinib—kidney cancer	0.00407	0.00414	CcSEcCtD
Fenoldopam—Nasal congestion—Paclitaxel—kidney cancer	0.004	0.00408	CcSEcCtD
Fenoldopam—Hypokalaemia—Gemcitabine—kidney cancer	0.00396	0.00404	CcSEcCtD
Fenoldopam—Haemoglobin—Sorafenib—kidney cancer	0.00392	0.00399	CcSEcCtD
Fenoldopam—Hyperhidrosis—Pazopanib—kidney cancer	0.00391	0.00398	CcSEcCtD
Fenoldopam—Haemorrhage—Sorafenib—kidney cancer	0.0039	0.00397	CcSEcCtD
Fenoldopam—Insomnia—Temsirolimus—kidney cancer	0.00388	0.00395	CcSEcCtD
Fenoldopam—Dyspnoea—Temsirolimus—kidney cancer	0.00383	0.0039	CcSEcCtD
Fenoldopam—Bradycardia—Sunitinib—kidney cancer	0.00382	0.00389	CcSEcCtD
Fenoldopam—Back pain—Everolimus—kidney cancer	0.00379	0.00385	CcSEcCtD
Fenoldopam—Haemoglobin—Sunitinib—kidney cancer	0.00377	0.00384	CcSEcCtD
Fenoldopam—Muscle spasms—Everolimus—kidney cancer	0.00376	0.00383	CcSEcCtD
Fenoldopam—Haemorrhage—Sunitinib—kidney cancer	0.00376	0.00382	CcSEcCtD
Fenoldopam—Cardiac failure—Paclitaxel—kidney cancer	0.00374	0.0038	CcSEcCtD
Fenoldopam—Constipation—Temsirolimus—kidney cancer	0.00367	0.00374	CcSEcCtD
Fenoldopam—Insomnia—Pazopanib—kidney cancer	0.00366	0.00372	CcSEcCtD
Fenoldopam—Back pain—Erlotinib—kidney cancer	0.00365	0.00372	CcSEcCtD
Fenoldopam—Flushing—Sorafenib—kidney cancer	0.00362	0.00369	CcSEcCtD
Fenoldopam—Dyspnoea—Pazopanib—kidney cancer	0.00361	0.00367	CcSEcCtD
Fenoldopam—Gastrointestinal pain—Temsirolimus—kidney cancer	0.00351	0.00357	CcSEcCtD
Fenoldopam—Acute coronary syndrome—Vincristine—kidney cancer	0.00349	0.00355	CcSEcCtD
Fenoldopam—Flushing—Sunitinib—kidney cancer	0.00349	0.00355	CcSEcCtD
Fenoldopam—Myocardial infarction—Vincristine—kidney cancer	0.00347	0.00353	CcSEcCtD
Fenoldopam—Palpitations—Everolimus—kidney cancer	0.00346	0.00352	CcSEcCtD
Fenoldopam—Blood creatinine increased—Paclitaxel—kidney cancer	0.00342	0.00348	CcSEcCtD
Fenoldopam—Abdominal pain—Temsirolimus—kidney cancer	0.00339	0.00346	CcSEcCtD
Fenoldopam—Body temperature increased—Temsirolimus—kidney cancer	0.00339	0.00346	CcSEcCtD
Fenoldopam—Sweating—Vincristine—kidney cancer	0.00339	0.00345	CcSEcCtD
Fenoldopam—Chest pain—Everolimus—kidney cancer	0.00333	0.00339	CcSEcCtD
Fenoldopam—Orthostatic hypotension—Paclitaxel—kidney cancer	0.00333	0.00339	CcSEcCtD
Fenoldopam—Anxiety—Everolimus—kidney cancer	0.00332	0.00338	CcSEcCtD
Fenoldopam—Hypokalaemia—Paclitaxel—kidney cancer	0.00332	0.00338	CcSEcCtD
Fenoldopam—Acute coronary syndrome—Gemcitabine—kidney cancer	0.00331	0.00337	CcSEcCtD
Fenoldopam—Gastrointestinal pain—Pazopanib—kidney cancer	0.00331	0.00337	CcSEcCtD
Fenoldopam—Flushing—Dactinomycin—kidney cancer	0.0033	0.00336	CcSEcCtD
Fenoldopam—Myocardial infarction—Gemcitabine—kidney cancer	0.00329	0.00335	CcSEcCtD
Fenoldopam—Muscle spasms—Sorafenib—kidney cancer	0.00327	0.00333	CcSEcCtD
Fenoldopam—Sweating—Gemcitabine—kidney cancer	0.00322	0.00328	CcSEcCtD
Fenoldopam—Chest pain—Erlotinib—kidney cancer	0.00322	0.00327	CcSEcCtD
Fenoldopam—Anxiety—Erlotinib—kidney cancer	0.0032	0.00326	CcSEcCtD
Fenoldopam—Abdominal pain—Pazopanib—kidney cancer	0.0032	0.00326	CcSEcCtD
Fenoldopam—Back pain—Sunitinib—kidney cancer	0.00316	0.00322	CcSEcCtD
Fenoldopam—Muscle spasms—Sunitinib—kidney cancer	0.00314	0.0032	CcSEcCtD
Fenoldopam—Tachycardia—Everolimus—kidney cancer	0.00312	0.00317	CcSEcCtD
Fenoldopam—Hyperhidrosis—Everolimus—kidney cancer	0.00309	0.00314	CcSEcCtD
Fenoldopam—Cardiac failure—Capecitabine—kidney cancer	0.00307	0.00312	CcSEcCtD
Fenoldopam—Haemoglobin—Gemcitabine—kidney cancer	0.00303	0.00308	CcSEcCtD
Fenoldopam—Haemorrhage—Gemcitabine—kidney cancer	0.00301	0.00307	CcSEcCtD
Fenoldopam—Hypotension—Everolimus—kidney cancer	0.00299	0.00304	CcSEcCtD
Fenoldopam—Diarrhoea—Temsirolimus—kidney cancer	0.00294	0.00299	CcSEcCtD
Fenoldopam—Insomnia—Everolimus—kidney cancer	0.00289	0.00294	CcSEcCtD
Fenoldopam—Oliguria—Doxorubicin—kidney cancer	0.00288	0.00294	CcSEcCtD
Fenoldopam—Dyspnoea—Everolimus—kidney cancer	0.00285	0.0029	CcSEcCtD
Fenoldopam—Dizziness—Temsirolimus—kidney cancer	0.00284	0.00289	CcSEcCtD
Fenoldopam—Blood creatinine increased—Capecitabine—kidney cancer	0.0028	0.00285	CcSEcCtD
Fenoldopam—Creatinine increased—Doxorubicin—kidney cancer	0.00279	0.00284	CcSEcCtD
Fenoldopam—Insomnia—Erlotinib—kidney cancer	0.00279	0.00284	CcSEcCtD
Fenoldopam—Chest pain—Sunitinib—kidney cancer	0.00278	0.00283	CcSEcCtD
Fenoldopam—Acute coronary syndrome—Paclitaxel—kidney cancer	0.00277	0.00282	CcSEcCtD
Fenoldopam—Diarrhoea—Pazopanib—kidney cancer	0.00277	0.00282	CcSEcCtD
Fenoldopam—Myocardial infarction—Paclitaxel—kidney cancer	0.00276	0.0028	CcSEcCtD
Fenoldopam—Dyspnoea—Erlotinib—kidney cancer	0.00275	0.0028	CcSEcCtD
Fenoldopam—Constipation—Vinblastine—kidney cancer	0.00274	0.00279	CcSEcCtD
Fenoldopam—Orthostatic hypotension—Capecitabine—kidney cancer	0.00273	0.00278	CcSEcCtD
Fenoldopam—Urinary tract infection—Paclitaxel—kidney cancer	0.00273	0.00278	CcSEcCtD
Fenoldopam—Constipation—Everolimus—kidney cancer	0.00273	0.00278	CcSEcCtD
Fenoldopam—Vomiting—Temsirolimus—kidney cancer	0.00273	0.00278	CcSEcCtD
Fenoldopam—Hypokalaemia—Capecitabine—kidney cancer	0.00272	0.00277	CcSEcCtD
Fenoldopam—Headache—Temsirolimus—kidney cancer	0.00269	0.00274	CcSEcCtD
Fenoldopam—Dizziness—Pazopanib—kidney cancer	0.00268	0.00272	CcSEcCtD
Fenoldopam—Back pain—Vincristine—kidney cancer	0.00267	0.00272	CcSEcCtD
Fenoldopam—Injection site reaction—Doxorubicin—kidney cancer	0.00264	0.00269	CcSEcCtD
Fenoldopam—Constipation—Erlotinib—kidney cancer	0.00264	0.00268	CcSEcCtD
Fenoldopam—Gastrointestinal pain—Vinblastine—kidney cancer	0.00262	0.00267	CcSEcCtD
Fenoldopam—Gastrointestinal pain—Everolimus—kidney cancer	0.00261	0.00266	CcSEcCtD
Fenoldopam—Vomiting—Pazopanib—kidney cancer	0.00257	0.00262	CcSEcCtD
Fenoldopam—Bradycardia—Paclitaxel—kidney cancer	0.00257	0.00261	CcSEcCtD
Fenoldopam—Nausea—Temsirolimus—kidney cancer	0.00255	0.0026	CcSEcCtD
Fenoldopam—Back pain—Gemcitabine—kidney cancer	0.00254	0.00258	CcSEcCtD
Fenoldopam—Haemoglobin—Paclitaxel—kidney cancer	0.00254	0.00258	CcSEcCtD
Fenoldopam—Abdominal pain—Vinblastine—kidney cancer	0.00254	0.00258	CcSEcCtD
Fenoldopam—Headache—Pazopanib—kidney cancer	0.00253	0.00258	CcSEcCtD
Fenoldopam—Abdominal pain—Everolimus—kidney cancer	0.00253	0.00257	CcSEcCtD
Fenoldopam—Body temperature increased—Everolimus—kidney cancer	0.00253	0.00257	CcSEcCtD
Fenoldopam—Haemorrhage—Paclitaxel—kidney cancer	0.00252	0.00257	CcSEcCtD
Fenoldopam—Gastrointestinal pain—Erlotinib—kidney cancer	0.00252	0.00257	CcSEcCtD
Fenoldopam—Angina pectoris—Capecitabine—kidney cancer	0.00252	0.00257	CcSEcCtD
Fenoldopam—Blood urea increased—Doxorubicin—kidney cancer	0.00251	0.00255	CcSEcCtD
Fenoldopam—Dyspnoea—Sorafenib—kidney cancer	0.00247	0.00252	CcSEcCtD
Fenoldopam—Body temperature increased—Erlotinib—kidney cancer	0.00244	0.00248	CcSEcCtD
Fenoldopam—Abdominal pain—Erlotinib—kidney cancer	0.00244	0.00248	CcSEcCtD
Fenoldopam—Insomnia—Sunitinib—kidney cancer	0.00241	0.00246	CcSEcCtD
Fenoldopam—Nausea—Pazopanib—kidney cancer	0.0024	0.00245	CcSEcCtD
Fenoldopam—Dyspnoea—Sunitinib—kidney cancer	0.00238	0.00242	CcSEcCtD
Fenoldopam—Constipation—Sorafenib—kidney cancer	0.00237	0.00241	CcSEcCtD
Fenoldopam—Flushing—Paclitaxel—kidney cancer	0.00234	0.00238	CcSEcCtD
Fenoldopam—Constipation—Sunitinib—kidney cancer	0.00228	0.00232	CcSEcCtD
Fenoldopam—Acute coronary syndrome—Capecitabine—kidney cancer	0.00227	0.00231	CcSEcCtD
Fenoldopam—Gastrointestinal pain—Sorafenib—kidney cancer	0.00227	0.00231	CcSEcCtD
Fenoldopam—Myocardial infarction—Capecitabine—kidney cancer	0.00226	0.0023	CcSEcCtD
Fenoldopam—Urinary tract infection—Capecitabine—kidney cancer	0.00224	0.00228	CcSEcCtD
Fenoldopam—Chest pain—Gemcitabine—kidney cancer	0.00223	0.00227	CcSEcCtD
Fenoldopam—Diarrhoea—Vinblastine—kidney cancer	0.00219	0.00223	CcSEcCtD
Fenoldopam—Body temperature increased—Sorafenib—kidney cancer	0.00219	0.00223	CcSEcCtD
Fenoldopam—Abdominal pain—Sorafenib—kidney cancer	0.00219	0.00223	CcSEcCtD
Fenoldopam—Diarrhoea—Everolimus—kidney cancer	0.00219	0.00222	CcSEcCtD
Fenoldopam—Gastrointestinal pain—Sunitinib—kidney cancer	0.00218	0.00222	CcSEcCtD
Fenoldopam—Hyperhidrosis—Vincristine—kidney cancer	0.00218	0.00222	CcSEcCtD
Fenoldopam—Tension—Paclitaxel—kidney cancer	0.00216	0.00219	CcSEcCtD
Fenoldopam—Nervousness—Paclitaxel—kidney cancer	0.00213	0.00217	CcSEcCtD
Fenoldopam—Back pain—Paclitaxel—kidney cancer	0.00212	0.00216	CcSEcCtD
Fenoldopam—Dizziness—Vinblastine—kidney cancer	0.00212	0.00216	CcSEcCtD
Fenoldopam—Dizziness—Everolimus—kidney cancer	0.00211	0.00215	CcSEcCtD
Fenoldopam—Muscle spasms—Paclitaxel—kidney cancer	0.00211	0.00215	CcSEcCtD
Fenoldopam—Abdominal pain—Sunitinib—kidney cancer	0.00211	0.00215	CcSEcCtD
Fenoldopam—Body temperature increased—Sunitinib—kidney cancer	0.00211	0.00215	CcSEcCtD
Fenoldopam—Diarrhoea—Erlotinib—kidney cancer	0.00211	0.00215	CcSEcCtD
Fenoldopam—Hypotension—Vincristine—kidney cancer	0.00211	0.00215	CcSEcCtD
Fenoldopam—Bradycardia—Capecitabine—kidney cancer	0.00211	0.00215	CcSEcCtD
Fenoldopam—Haemoglobin—Capecitabine—kidney cancer	0.00208	0.00212	CcSEcCtD
Fenoldopam—Haemorrhage—Capecitabine—kidney cancer	0.00207	0.00211	CcSEcCtD
Fenoldopam—Hyperhidrosis—Gemcitabine—kidney cancer	0.00207	0.00211	CcSEcCtD
Fenoldopam—Gastrointestinal pain—Dactinomycin—kidney cancer	0.00207	0.0021	CcSEcCtD
Fenoldopam—Insomnia—Vincristine—kidney cancer	0.00204	0.00208	CcSEcCtD
Fenoldopam—Vomiting—Vinblastine—kidney cancer	0.00204	0.00208	CcSEcCtD
Fenoldopam—Dizziness—Erlotinib—kidney cancer	0.00204	0.00207	CcSEcCtD
Fenoldopam—Vomiting—Everolimus—kidney cancer	0.00203	0.00207	CcSEcCtD
Fenoldopam—Headache—Vinblastine—kidney cancer	0.00201	0.00205	CcSEcCtD
Fenoldopam—Headache—Everolimus—kidney cancer	0.002	0.00204	CcSEcCtD
Fenoldopam—Hypotension—Gemcitabine—kidney cancer	0.002	0.00204	CcSEcCtD
Fenoldopam—Abdominal pain—Dactinomycin—kidney cancer	0.002	0.00203	CcSEcCtD
Fenoldopam—Body temperature increased—Dactinomycin—kidney cancer	0.002	0.00203	CcSEcCtD
Fenoldopam—Cardiac failure—Doxorubicin—kidney cancer	0.00198	0.00201	CcSEcCtD
Fenoldopam—Vomiting—Erlotinib—kidney cancer	0.00196	0.00199	CcSEcCtD
Fenoldopam—Palpitations—Paclitaxel—kidney cancer	0.00194	0.00198	CcSEcCtD
Fenoldopam—Insomnia—Gemcitabine—kidney cancer	0.00194	0.00197	CcSEcCtD
Fenoldopam—Headache—Erlotinib—kidney cancer	0.00193	0.00197	CcSEcCtD
Fenoldopam—Constipation—Vincristine—kidney cancer	0.00193	0.00196	CcSEcCtD
Fenoldopam—Flushing—Capecitabine—kidney cancer	0.00192	0.00196	CcSEcCtD
Fenoldopam—Dyspnoea—Gemcitabine—kidney cancer	0.00191	0.00194	CcSEcCtD
Fenoldopam—Nausea—Vinblastine—kidney cancer	0.0019	0.00194	CcSEcCtD
Fenoldopam—Nausea—Everolimus—kidney cancer	0.0019	0.00193	CcSEcCtD
Fenoldopam—Diarrhoea—Sorafenib—kidney cancer	0.0019	0.00193	CcSEcCtD
Fenoldopam—Chest pain—Paclitaxel—kidney cancer	0.00187	0.0019	CcSEcCtD
Fenoldopam—Anxiety—Paclitaxel—kidney cancer	0.00186	0.0019	CcSEcCtD
Fenoldopam—Gastrointestinal pain—Vincristine—kidney cancer	0.00185	0.00188	CcSEcCtD
Fenoldopam—Dizziness—Sorafenib—kidney cancer	0.00183	0.00187	CcSEcCtD
Fenoldopam—Constipation—Gemcitabine—kidney cancer	0.00183	0.00186	CcSEcCtD
Fenoldopam—Nausea—Erlotinib—kidney cancer	0.00183	0.00186	CcSEcCtD
Fenoldopam—Diarrhoea—Sunitinib—kidney cancer	0.00183	0.00186	CcSEcCtD
Fenoldopam—Blood creatinine increased—Doxorubicin—kidney cancer	0.00181	0.00184	CcSEcCtD
Fenoldopam—Body temperature increased—Vincristine—kidney cancer	0.00178	0.00182	CcSEcCtD
Fenoldopam—Abdominal pain—Vincristine—kidney cancer	0.00178	0.00182	CcSEcCtD
Fenoldopam—Dizziness—Sunitinib—kidney cancer	0.00176	0.0018	CcSEcCtD
Fenoldopam—Vomiting—Sorafenib—kidney cancer	0.00176	0.00179	CcSEcCtD
Fenoldopam—Orthostatic hypotension—Doxorubicin—kidney cancer	0.00176	0.00179	CcSEcCtD
Fenoldopam—Hypokalaemia—Doxorubicin—kidney cancer	0.00176	0.00179	CcSEcCtD
Fenoldopam—Tachycardia—Paclitaxel—kidney cancer	0.00175	0.00178	CcSEcCtD
Fenoldopam—Back pain—Capecitabine—kidney cancer	0.00174	0.00177	CcSEcCtD
Fenoldopam—Headache—Sorafenib—kidney cancer	0.00174	0.00177	CcSEcCtD
Fenoldopam—Muscle spasms—Capecitabine—kidney cancer	0.00173	0.00176	CcSEcCtD
Fenoldopam—Hyperhidrosis—Paclitaxel—kidney cancer	0.00173	0.00176	CcSEcCtD
Fenoldopam—Diarrhoea—Dactinomycin—kidney cancer	0.00173	0.00176	CcSEcCtD
Fenoldopam—Vomiting—Sunitinib—kidney cancer	0.0017	0.00173	CcSEcCtD
Fenoldopam—Body temperature increased—Gemcitabine—kidney cancer	0.00169	0.00172	CcSEcCtD
Fenoldopam—Hypotension—Paclitaxel—kidney cancer	0.00167	0.00171	CcSEcCtD
Fenoldopam—Headache—Sunitinib—kidney cancer	0.00167	0.0017	CcSEcCtD
Fenoldopam—Nausea—Sorafenib—kidney cancer	0.00165	0.00168	CcSEcCtD
Fenoldopam—Angina pectoris—Doxorubicin—kidney cancer	0.00162	0.00165	CcSEcCtD
Fenoldopam—Insomnia—Paclitaxel—kidney cancer	0.00162	0.00165	CcSEcCtD
Fenoldopam—Vomiting—Dactinomycin—kidney cancer	0.00161	0.00163	CcSEcCtD
Fenoldopam—Dyspnoea—Paclitaxel—kidney cancer	0.0016	0.00163	CcSEcCtD
Fenoldopam—Palpitations—Capecitabine—kidney cancer	0.00159	0.00162	CcSEcCtD
Fenoldopam—Nausea—Sunitinib—kidney cancer	0.00158	0.00161	CcSEcCtD
Fenoldopam—Diarrhoea—Vincristine—kidney cancer	0.00154	0.00157	CcSEcCtD
Fenoldopam—Chest pain—Capecitabine—kidney cancer	0.00153	0.00156	CcSEcCtD
Fenoldopam—Constipation—Paclitaxel—kidney cancer	0.00153	0.00156	CcSEcCtD
Fenoldopam—Anxiety—Capecitabine—kidney cancer	0.00153	0.00156	CcSEcCtD
Fenoldopam—Nausea—Dactinomycin—kidney cancer	0.0015	0.00153	CcSEcCtD
Fenoldopam—Dizziness—Vincristine—kidney cancer	0.00149	0.00152	CcSEcCtD
Fenoldopam—Gastrointestinal pain—Paclitaxel—kidney cancer	0.00147	0.00149	CcSEcCtD
Fenoldopam—Diarrhoea—Gemcitabine—kidney cancer	0.00146	0.00149	CcSEcCtD
Fenoldopam—Urinary tract infection—Doxorubicin—kidney cancer	0.00145	0.00147	CcSEcCtD
Fenoldopam—Tachycardia—Capecitabine—kidney cancer	0.00144	0.00146	CcSEcCtD
Fenoldopam—Vomiting—Vincristine—kidney cancer	0.00143	0.00146	CcSEcCtD
Fenoldopam—Sweating—Doxorubicin—kidney cancer	0.00143	0.00145	CcSEcCtD
Fenoldopam—Hyperhidrosis—Capecitabine—kidney cancer	0.00142	0.00145	CcSEcCtD
Fenoldopam—Abdominal pain—Paclitaxel—kidney cancer	0.00142	0.00144	CcSEcCtD
Fenoldopam—Body temperature increased—Paclitaxel—kidney cancer	0.00142	0.00144	CcSEcCtD
Fenoldopam—Headache—Vincristine—kidney cancer	0.00141	0.00144	CcSEcCtD
Fenoldopam—Hypotension—Capecitabine—kidney cancer	0.00137	0.0014	CcSEcCtD
Fenoldopam—Vomiting—Gemcitabine—kidney cancer	0.00136	0.00139	CcSEcCtD
Fenoldopam—Bradycardia—Doxorubicin—kidney cancer	0.00136	0.00138	CcSEcCtD
Fenoldopam—Haemoglobin—Doxorubicin—kidney cancer	0.00134	0.00137	CcSEcCtD
Fenoldopam—Headache—Gemcitabine—kidney cancer	0.00134	0.00137	CcSEcCtD
Fenoldopam—Nausea—Vincristine—kidney cancer	0.00134	0.00136	CcSEcCtD
Fenoldopam—Haemorrhage—Doxorubicin—kidney cancer	0.00133	0.00136	CcSEcCtD
Fenoldopam—Insomnia—Capecitabine—kidney cancer	0.00133	0.00135	CcSEcCtD
Fenoldopam—Dyspnoea—Capecitabine—kidney cancer	0.00131	0.00134	CcSEcCtD
Fenoldopam—Nausea—Gemcitabine—kidney cancer	0.00127	0.00129	CcSEcCtD
Fenoldopam—Constipation—Capecitabine—kidney cancer	0.00126	0.00128	CcSEcCtD
Fenoldopam—Flushing—Doxorubicin—kidney cancer	0.00124	0.00126	CcSEcCtD
Fenoldopam—Diarrhoea—Paclitaxel—kidney cancer	0.00123	0.00125	CcSEcCtD
Fenoldopam—Gastrointestinal pain—Capecitabine—kidney cancer	0.0012	0.00122	CcSEcCtD
Fenoldopam—Dizziness—Paclitaxel—kidney cancer	0.00119	0.00121	CcSEcCtD
Fenoldopam—Body temperature increased—Capecitabine—kidney cancer	0.00116	0.00118	CcSEcCtD
Fenoldopam—Abdominal pain—Capecitabine—kidney cancer	0.00116	0.00118	CcSEcCtD
Fenoldopam—Tension—Doxorubicin—kidney cancer	0.00114	0.00116	CcSEcCtD
Fenoldopam—Vomiting—Paclitaxel—kidney cancer	0.00114	0.00116	CcSEcCtD
Fenoldopam—Nervousness—Doxorubicin—kidney cancer	0.00113	0.00115	CcSEcCtD
Fenoldopam—Back pain—Doxorubicin—kidney cancer	0.00112	0.00114	CcSEcCtD
Fenoldopam—Headache—Paclitaxel—kidney cancer	0.00112	0.00114	CcSEcCtD
Fenoldopam—Muscle spasms—Doxorubicin—kidney cancer	0.00112	0.00114	CcSEcCtD
Fenoldopam—Nausea—Paclitaxel—kidney cancer	0.00106	0.00108	CcSEcCtD
Fenoldopam—Palpitations—Doxorubicin—kidney cancer	0.00103	0.00105	CcSEcCtD
Fenoldopam—Diarrhoea—Capecitabine—kidney cancer	0.00101	0.00102	CcSEcCtD
Fenoldopam—Chest pain—Doxorubicin—kidney cancer	0.000989	0.00101	CcSEcCtD
Fenoldopam—Anxiety—Doxorubicin—kidney cancer	0.000986	0.001	CcSEcCtD
Fenoldopam—Dizziness—Capecitabine—kidney cancer	0.000973	0.00099	CcSEcCtD
Fenoldopam—Vomiting—Capecitabine—kidney cancer	0.000935	0.000952	CcSEcCtD
Fenoldopam—Tachycardia—Doxorubicin—kidney cancer	0.000925	0.000942	CcSEcCtD
Fenoldopam—Headache—Capecitabine—kidney cancer	0.000922	0.000938	CcSEcCtD
Fenoldopam—Hyperhidrosis—Doxorubicin—kidney cancer	0.000917	0.000933	CcSEcCtD
Fenoldopam—Hypotension—Doxorubicin—kidney cancer	0.000886	0.000902	CcSEcCtD
Fenoldopam—Nausea—Capecitabine—kidney cancer	0.000874	0.000889	CcSEcCtD
Fenoldopam—Insomnia—Doxorubicin—kidney cancer	0.000858	0.000873	CcSEcCtD
Fenoldopam—Dyspnoea—Doxorubicin—kidney cancer	0.000845	0.000861	CcSEcCtD
Fenoldopam—Constipation—Doxorubicin—kidney cancer	0.000811	0.000825	CcSEcCtD
Fenoldopam—Gastrointestinal pain—Doxorubicin—kidney cancer	0.000775	0.000789	CcSEcCtD
Fenoldopam—Body temperature increased—Doxorubicin—kidney cancer	0.00075	0.000763	CcSEcCtD
Fenoldopam—Abdominal pain—Doxorubicin—kidney cancer	0.00075	0.000763	CcSEcCtD
Fenoldopam—Diarrhoea—Doxorubicin—kidney cancer	0.000649	0.00066	CcSEcCtD
Fenoldopam—Dizziness—Doxorubicin—kidney cancer	0.000627	0.000638	CcSEcCtD
Fenoldopam—Vomiting—Doxorubicin—kidney cancer	0.000603	0.000614	CcSEcCtD
Fenoldopam—Headache—Doxorubicin—kidney cancer	0.000594	0.000605	CcSEcCtD
Fenoldopam—Nausea—Doxorubicin—kidney cancer	0.000563	0.000573	CcSEcCtD
Fenoldopam—ADRA1D—Signaling Pathways—KIT—kidney cancer	5.84e-06	0.000331	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—APC—kidney cancer	5.84e-06	0.000331	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling by GPCR—IL2—kidney cancer	5.77e-06	0.000328	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—KDR—kidney cancer	5.72e-06	0.000325	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling by GPCR—RAF1—kidney cancer	5.72e-06	0.000325	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—IGF2—kidney cancer	5.7e-06	0.000324	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—CDKN2B—kidney cancer	5.68e-06	0.000322	CbGpPWpGaD
Fenoldopam—DRD1—Signaling by GPCR—MAPK3—kidney cancer	5.67e-06	0.000322	CbGpPWpGaD
Fenoldopam—ADRA1A—GPCR downstream signaling—IL2—kidney cancer	5.65e-06	0.00032	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—POMC—kidney cancer	5.63e-06	0.00032	CbGpPWpGaD
Fenoldopam—ADRA2C—Metabolism—POMC—kidney cancer	5.61e-06	0.000318	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling by GPCR—MAPK3—kidney cancer	5.59e-06	0.000317	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—HIF1A—kidney cancer	5.59e-06	0.000317	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—TSC2—kidney cancer	5.58e-06	0.000316	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—BRAF—kidney cancer	5.56e-06	0.000316	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—POMC—kidney cancer	5.56e-06	0.000315	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—IGF1R—kidney cancer	5.51e-06	0.000313	CbGpPWpGaD
Fenoldopam—ADRA2A—Hemostasis—PIK3CA—kidney cancer	5.51e-06	0.000313	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—HIF1A—kidney cancer	5.5e-06	0.000312	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—BRAF—kidney cancer	5.49e-06	0.000311	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—TSC2—kidney cancer	5.49e-06	0.000311	CbGpPWpGaD
Fenoldopam—DRD1—Signaling by GPCR—MAPK1—kidney cancer	5.39e-06	0.000306	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—KDR—kidney cancer	5.35e-06	0.000303	CbGpPWpGaD
Fenoldopam—ADRA2A—Hemostasis—TP53—kidney cancer	5.33e-06	0.000302	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—VEGFA—kidney cancer	5.33e-06	0.000302	CbGpPWpGaD
Fenoldopam—DRD2—Signaling by GPCR—IL2—kidney cancer	5.32e-06	0.000302	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling by GPCR—MAPK1—kidney cancer	5.32e-06	0.000302	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling by GPCR—RAF1—kidney cancer	5.31e-06	0.000302	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—APC—kidney cancer	5.27e-06	0.000299	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—KIT—kidney cancer	5.27e-06	0.000299	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—KDR—kidney cancer	5.26e-06	0.000299	CbGpPWpGaD
Fenoldopam—ADRA2A—GPCR downstream signaling—IL2—kidney cancer	5.25e-06	0.000298	CbGpPWpGaD
Fenoldopam—DRD1—GPCR downstream signaling—PIK3CA—kidney cancer	5.15e-06	0.000292	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling by GPCR—IL2—kidney cancer	5.13e-06	0.000291	CbGpPWpGaD
Fenoldopam—DRD1—Signaling by GPCR—KRAS—kidney cancer	5.09e-06	0.000289	CbGpPWpGaD
Fenoldopam—ADRA1D—GPCR downstream signaling—PIK3CA—kidney cancer	5.08e-06	0.000288	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—HIF1A—kidney cancer	5.07e-06	0.000288	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—TSC2—kidney cancer	5.06e-06	0.000287	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling by GPCR—MAPK3—kidney cancer	5.05e-06	0.000286	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—MAPK3—kidney cancer	5.04e-06	0.000286	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling by GPCR—KRAS—kidney cancer	5.03e-06	0.000285	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—POMC—kidney cancer	5.02e-06	0.000285	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—BRAF—kidney cancer	4.95e-06	0.000281	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—APC—kidney cancer	4.92e-06	0.000279	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—KIT—kidney cancer	4.92e-06	0.000279	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—MYC—kidney cancer	4.9e-06	0.000278	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—HIF1A—kidney cancer	4.89e-06	0.000277	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—TSC2—kidney cancer	4.87e-06	0.000277	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—KDR—kidney cancer	4.85e-06	0.000275	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—KIT—kidney cancer	4.85e-06	0.000275	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—APC—kidney cancer	4.85e-06	0.000275	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling by GPCR—MAPK1—kidney cancer	4.8e-06	0.000273	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—MAPK1—kidney cancer	4.79e-06	0.000272	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling by GPCR—IL2—kidney cancer	4.76e-06	0.00027	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling by GPCR—MAPK3—kidney cancer	4.72e-06	0.000268	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—POMC—kidney cancer	4.69e-06	0.000266	CbGpPWpGaD
Fenoldopam—DRD1—Signaling by GPCR—PIK3CA—kidney cancer	4.68e-06	0.000266	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—KDR—kidney cancer	4.67e-06	0.000265	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—RAF1—kidney cancer	4.64e-06	0.000264	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling by GPCR—MAPK3—kidney cancer	4.64e-06	0.000263	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—BRAF—kidney cancer	4.63e-06	0.000263	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—RELA—kidney cancer	4.62e-06	0.000262	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling by GPCR—PIK3CA—kidney cancer	4.62e-06	0.000262	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—POMC—kidney cancer	4.61e-06	0.000262	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—ERBB2—kidney cancer	4.59e-06	0.000261	CbGpPWpGaD
Fenoldopam—ADRA2B—GPCR downstream signaling—PIK3CA—kidney cancer	4.59e-06	0.00026	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—RAF1—kidney cancer	4.58e-06	0.00026	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—RELA—kidney cancer	4.56e-06	0.000259	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—BRAF—kidney cancer	4.56e-06	0.000258	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—POMC—kidney cancer	4.55e-06	0.000258	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—HIF1A—kidney cancer	4.54e-06	0.000258	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling by GPCR—KRAS—kidney cancer	4.54e-06	0.000257	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—MTOR—kidney cancer	4.53e-06	0.000257	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—ERBB2—kidney cancer	4.53e-06	0.000257	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—TSC2—kidney cancer	4.53e-06	0.000257	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—KRAS—kidney cancer	4.53e-06	0.000257	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling by GPCR—MAPK1—kidney cancer	4.49e-06	0.000255	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—MTOR—kidney cancer	4.47e-06	0.000254	CbGpPWpGaD
Fenoldopam—ADRA2C—Metabolism—PTGS2—kidney cancer	4.47e-06	0.000254	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—APC—kidney cancer	4.47e-06	0.000254	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—KIT—kidney cancer	4.47e-06	0.000254	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling by GPCR—MAPK1—kidney cancer	4.42e-06	0.000251	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—KDR—kidney cancer	4.34e-06	0.000246	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—KIT—kidney cancer	4.3e-06	0.000244	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—APC—kidney cancer	4.3e-06	0.000244	CbGpPWpGaD
Fenoldopam—ADRA2C—GPCR downstream signaling—PIK3CA—kidney cancer	4.29e-06	0.000243	CbGpPWpGaD
Fenoldopam—DRD2—Signaling by GPCR—MAPK3—kidney cancer	4.28e-06	0.000243	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—CDKN1B—kidney cancer	4.26e-06	0.000241	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—POMC—kidney cancer	4.25e-06	0.000241	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling by GPCR—KRAS—kidney cancer	4.24e-06	0.00024	CbGpPWpGaD
Fenoldopam—ADRA1B—GPCR downstream signaling—PIK3CA—kidney cancer	4.22e-06	0.000239	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—BRAF—kidney cancer	4.2e-06	0.000238	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—CDKN1B—kidney cancer	4.2e-06	0.000238	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling by GPCR—KRAS—kidney cancer	4.17e-06	0.000237	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling by GPCR—PIK3CA—kidney cancer	4.17e-06	0.000237	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—IL2—kidney cancer	4.16e-06	0.000236	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—PIK3CA—kidney cancer	4.16e-06	0.000236	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—RAF1—kidney cancer	4.14e-06	0.000235	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling by GPCR—MAPK3—kidney cancer	4.12e-06	0.000234	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—RELA—kidney cancer	4.12e-06	0.000234	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—IL2—kidney cancer	4.11e-06	0.000233	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—POMC—kidney cancer	4.1e-06	0.000232	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—ERBB2—kidney cancer	4.09e-06	0.000232	CbGpPWpGaD
Fenoldopam—DRD2—Signaling by GPCR—MAPK1—kidney cancer	4.07e-06	0.000231	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—CCND1—kidney cancer	4.06e-06	0.00023	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—JUN—kidney cancer	4.05e-06	0.00023	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—BRAF—kidney cancer	4.05e-06	0.00023	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—MTOR—kidney cancer	4.04e-06	0.000229	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—TP53—kidney cancer	4.02e-06	0.000228	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—CTNNB1—kidney cancer	4.02e-06	0.000228	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—CCND1—kidney cancer	4.01e-06	0.000227	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—APC—kidney cancer	4e-06	0.000227	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—KIT—kidney cancer	4e-06	0.000227	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—JUN—kidney cancer	4e-06	0.000227	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—CTNNB1—kidney cancer	3.97e-06	0.000225	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling by GPCR—MAPK1—kidney cancer	3.92e-06	0.000223	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—PTEN—kidney cancer	3.92e-06	0.000222	CbGpPWpGaD
Fenoldopam—ADRA2C—Metabolism—PTEN—kidney cancer	3.9e-06	0.000221	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling by GPCR—PIK3CA—kidney cancer	3.89e-06	0.000221	CbGpPWpGaD
Fenoldopam—DRD2—GPCR downstream signaling—PIK3CA—kidney cancer	3.89e-06	0.000221	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—PTEN—kidney cancer	3.87e-06	0.000219	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—RAF1—kidney cancer	3.86e-06	0.000219	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—RELA—kidney cancer	3.85e-06	0.000218	CbGpPWpGaD
Fenoldopam—DRD2—Signaling by GPCR—KRAS—kidney cancer	3.85e-06	0.000218	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling by GPCR—PIK3CA—kidney cancer	3.83e-06	0.000217	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling by GPCR—MAPK3—kidney cancer	3.83e-06	0.000217	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—ERBB2—kidney cancer	3.82e-06	0.000217	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—POMC—kidney cancer	3.81e-06	0.000216	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—RAF1—kidney cancer	3.8e-06	0.000216	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—CDKN1B—kidney cancer	3.79e-06	0.000215	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—RELA—kidney cancer	3.79e-06	0.000215	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—MTOR—kidney cancer	3.77e-06	0.000214	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—ERBB2—kidney cancer	3.76e-06	0.000214	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—BRAF—kidney cancer	3.76e-06	0.000213	CbGpPWpGaD
Fenoldopam—ADRA1A—GPCR downstream signaling—PIK3CA—kidney cancer	3.75e-06	0.000213	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—MTOR—kidney cancer	3.71e-06	0.000211	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—IL2—kidney cancer	3.71e-06	0.00021	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling by GPCR—KRAS—kidney cancer	3.7e-06	0.00021	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling by GPCR—MAPK1—kidney cancer	3.64e-06	0.000207	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—PTGS2—kidney cancer	3.63e-06	0.000206	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—CCND1—kidney cancer	3.62e-06	0.000205	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—JUN—kidney cancer	3.61e-06	0.000205	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—CTNNB1—kidney cancer	3.58e-06	0.000203	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—CDKN1B—kidney cancer	3.54e-06	0.000201	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—VEGFA—kidney cancer	3.54e-06	0.000201	CbGpPWpGaD
Fenoldopam—DRD2—Signaling by GPCR—PIK3CA—kidney cancer	3.53e-06	0.0002	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—RAF1—kidney cancer	3.51e-06	0.000199	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—VEGFA—kidney cancer	3.49e-06	0.000198	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—RELA—kidney cancer	3.49e-06	0.000198	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—PTEN—kidney cancer	3.49e-06	0.000198	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—CDKN1B—kidney cancer	3.48e-06	0.000198	CbGpPWpGaD
Fenoldopam—ADRA2A—GPCR downstream signaling—PIK3CA—kidney cancer	3.48e-06	0.000198	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—ERBB2—kidney cancer	3.47e-06	0.000197	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—IL2—kidney cancer	3.47e-06	0.000197	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling by GPCR—KRAS—kidney cancer	3.44e-06	0.000195	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—MTOR—kidney cancer	3.42e-06	0.000194	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—IL2—kidney cancer	3.41e-06	0.000194	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling by GPCR—PIK3CA—kidney cancer	3.4e-06	0.000193	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—RAF1—kidney cancer	3.38e-06	0.000192	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—CCND1—kidney cancer	3.38e-06	0.000192	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—JUN—kidney cancer	3.37e-06	0.000191	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—RELA—kidney cancer	3.36e-06	0.000191	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—MAPK3—kidney cancer	3.35e-06	0.00019	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—CTNNB1—kidney cancer	3.35e-06	0.00019	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—ERBB2—kidney cancer	3.34e-06	0.00019	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—CCND1—kidney cancer	3.32e-06	0.000189	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—JUN—kidney cancer	3.32e-06	0.000188	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—MAPK3—kidney cancer	3.3e-06	0.000187	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—MTOR—kidney cancer	3.3e-06	0.000187	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—CTNNB1—kidney cancer	3.29e-06	0.000187	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—PTEN—kidney cancer	3.26e-06	0.000185	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—MYC—kidney cancer	3.26e-06	0.000185	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—CDKN1B—kidney cancer	3.21e-06	0.000182	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—MYC—kidney cancer	3.21e-06	0.000182	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—PTEN—kidney cancer	3.21e-06	0.000182	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—MAPK1—kidney cancer	3.19e-06	0.000181	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—PTEN—kidney cancer	3.17e-06	0.00018	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling by GPCR—PIK3CA—kidney cancer	3.16e-06	0.000179	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—VEGFA—kidney cancer	3.15e-06	0.000179	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—IL2—kidney cancer	3.14e-06	0.000178	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—MAPK1—kidney cancer	3.14e-06	0.000178	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—RAF1—kidney cancer	3.14e-06	0.000178	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—RELA—kidney cancer	3.13e-06	0.000177	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—ERBB2—kidney cancer	3.11e-06	0.000176	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—CDKN1B—kidney cancer	3.1e-06	0.000176	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—CCND1—kidney cancer	3.06e-06	0.000174	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—MTOR—kidney cancer	3.06e-06	0.000174	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—JUN—kidney cancer	3.06e-06	0.000174	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—CTNNB1—kidney cancer	3.04e-06	0.000172	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—IL2—kidney cancer	3.03e-06	0.000172	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—KRAS—kidney cancer	3.01e-06	0.000171	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—MAPK3—kidney cancer	2.98e-06	0.000169	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—KRAS—kidney cancer	2.97e-06	0.000168	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—PTEN—kidney cancer	2.96e-06	0.000168	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—CCND1—kidney cancer	2.95e-06	0.000168	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—JUN—kidney cancer	2.95e-06	0.000167	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—VEGFA—kidney cancer	2.94e-06	0.000167	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—CTNNB1—kidney cancer	2.92e-06	0.000166	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—MYC—kidney cancer	2.9e-06	0.000165	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—VEGFA—kidney cancer	2.9e-06	0.000164	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—CDKN1B—kidney cancer	2.88e-06	0.000163	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—PTEN—kidney cancer	2.85e-06	0.000162	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—MAPK1—kidney cancer	2.84e-06	0.000161	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—IL2—kidney cancer	2.81e-06	0.00016	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—MAPK3—kidney cancer	2.79e-06	0.000158	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—PIK3CA—kidney cancer	2.76e-06	0.000157	CbGpPWpGaD
Fenoldopam—ADRA2C—Metabolism—PIK3CA—kidney cancer	2.75e-06	0.000156	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—CCND1—kidney cancer	2.74e-06	0.000156	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—MAPK3—kidney cancer	2.74e-06	0.000156	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—JUN—kidney cancer	2.74e-06	0.000155	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—PIK3CA—kidney cancer	2.73e-06	0.000155	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—CTNNB1—kidney cancer	2.72e-06	0.000154	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—MYC—kidney cancer	2.71e-06	0.000154	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—KRAS—kidney cancer	2.68e-06	0.000152	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—TP53—kidney cancer	2.67e-06	0.000152	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—VEGFA—kidney cancer	2.67e-06	0.000152	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—MYC—kidney cancer	2.67e-06	0.000151	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—MAPK1—kidney cancer	2.65e-06	0.00015	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—PTEN—kidney cancer	2.65e-06	0.00015	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—TP53—kidney cancer	2.64e-06	0.00015	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—MAPK1—kidney cancer	2.61e-06	0.000148	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—VEGFA—kidney cancer	2.57e-06	0.000146	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—MAPK3—kidney cancer	2.53e-06	0.000143	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—KRAS—kidney cancer	2.5e-06	0.000142	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—KRAS—kidney cancer	2.46e-06	0.00014	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—PIK3CA—kidney cancer	2.46e-06	0.00014	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—MYC—kidney cancer	2.46e-06	0.000139	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—MAPK3—kidney cancer	2.44e-06	0.000138	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—MAPK1—kidney cancer	2.41e-06	0.000136	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—VEGFA—kidney cancer	2.39e-06	0.000136	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—TP53—kidney cancer	2.38e-06	0.000135	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—MYC—kidney cancer	2.37e-06	0.000134	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—MAPK1—kidney cancer	2.32e-06	0.000131	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—PIK3CA—kidney cancer	2.3e-06	0.000131	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—KRAS—kidney cancer	2.27e-06	0.000129	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—PIK3CA—kidney cancer	2.26e-06	0.000128	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—MAPK3—kidney cancer	2.26e-06	0.000128	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—PIK3CA—kidney cancer	2.23e-06	0.000127	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—TP53—kidney cancer	2.23e-06	0.000126	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—MYC—kidney cancer	2.2e-06	0.000125	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—TP53—kidney cancer	2.19e-06	0.000124	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—KRAS—kidney cancer	2.19e-06	0.000124	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—MAPK1—kidney cancer	2.15e-06	0.000122	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—PIK3CA—kidney cancer	2.09e-06	0.000118	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—KRAS—kidney cancer	2.03e-06	0.000115	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—TP53—kidney cancer	2.02e-06	0.000115	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—PIK3CA—kidney cancer	2.01e-06	0.000114	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—TP53—kidney cancer	1.95e-06	0.00011	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—PIK3CA—kidney cancer	1.87e-06	0.000106	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—TP53—kidney cancer	1.81e-06	0.000103	CbGpPWpGaD
